LITTLETON, Colo. & NEWARK, Del.–Novus Biologicals, LLC and SDIX™ (Strategic Diagnostics Inc. d/b/a SDIX, NASDAQ: SDIX), announced today they have entered into an exclusive partnership for the creation and dissemination of premade Genomic Antibody Technology™ (GAT)™ polyclonal antibodies. Initial commercial efforts will focus on Novus’ dissemination of over 800 antibodies from SDIX’s premade collection of […]
Puchheim, Germany / b3c newswire / – Sloning, leading supplier of synthetic biology tools was awarded US Patent No, 7,695,906. Sloning’s enabling platform technology – Slonomics® – allows researchers to increase the success rate of their screening for new and optimized therapeutic antibodies, proteins or industrial enzymes. Key to Sloning’s success is the company’s core […]
ST. LOUIS — Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich® (Nasdaq:SIAL – News), today announced a significant expansion to its web-based biological research portal for exploring dynamic gene-based content, Your Favorite Gene Powered By Ingenuity (https://www.wherebiobegins.com/yfg). The latest version of Your Favorite Gene Powered By Ingenuity adds a biologically relevant […]
OCEANSIDE, Calif.–International Stem Cell Corporation (OTCBB:ISCO), www.intlstemcell.com, today added two world-leading immunogeneticists to its scientific advisory board. They and ISCO scientists will study the immune-matching properties of ISCO’s human parthenogenetic stem cell (hpSC) technology and the potential for each hpSC-derived therapeutic cell to be an immune-match for millions of people. “While stem cell technologies generally […]
A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significantly advance personalized medicine. The partnership will create a beginning-to-end solution for pharmaceutical and biotechnology companies to more rationally design and tailor their drugs to specific patient populations based on the unique genetic variations that define a given disease. TD2 […]
Proteome Sciences plc (“Proteome Sciences”) is pleased to announce that it has entered into a non-exclusive license agreement with Sigma-Aldrich Corporation (“Sigma”) under which Sigma will be able to continue selling products under Proteome’s registered trademark ProteoPrep® in Europe, Japan and Australia. Sigma is the world’s largest supplier of research biochemicals and organic chemicals with […]
Life Technologies acquires 58 % of GENEART shares via it´s German subsidiary Applied Biosystems Deutschland GmbH Public tender offer for the remaining shares planned Cooperation Agreement concluded with Life Technologies Regensburg — The founders of GENEART AG Prof. Dr. Ralf Wagner, Prof. Dr. Hans Wolf, Dr. Marcus Graf, and individual members of the management as […]
PerkinElmer’s Facilitates Screening of Complex G-Protein Coupled Receptors for Therapeutic Research Global leader in assay technologies enhances high throughput screening of GPCRs used in researching potential drug candidates for critical disease states PHOENIX–PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its new […]
PHOENIX–PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced its latest drug discovery solutions for global research institutions and biopharmaceutical companies at the Society for Biomolecular Sciences 2010, April 11-15 at Booth 701. “Primal Screening Innovations in Cellular Screening, Automation and Analysis” PerkinElmer will be showcasing […]
SAN DIEGO — TriLink BioTechnologies (TriLink), has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for the sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products. TriLink CEO, Richard Hogrefe, Ph.D. commented, “We are pleased to partner with Cedarlane to enhance the distribution of TriLink’s products […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
